Treatment with liraglutide, a glucagon-like peptide-1 analogue, improves effectively the skin lesions of psoriasis patients with type 2 diabetes: A prospective cohort study

Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans

Katherine Esposito, Francesco Nappo, Raffaele Marfella et al. · Circulation · 2002 · 2K citations

Medicine, Endocrinology, Physiology +17

Psoriasis and the Risk of Diabetes and Hypertension

Abrar A. Qureshi, Hyon K. Choi, Arathi R. Setty et al. · Archives of Dermatology · 2009 · 249 citations · Full text

Medicine, Dermatology, Health Sciences +10

Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis

Andrew E. Hogan, Anne‐Marie Tobin, Tomás Ahern et al. · Diabetologia · 2011 · 180 citations · Full text

Life Sciences, Endocrinology, Immunology +17

Psoriasis and the risk of diabetes: A prospective population-based cohort study

Marilyn T. Wan, Daniel B. Shin, Rebecca A. Hubbard et al. · Journal of the American Academy of Dermatology · 2017 · 137 citations

Medicine, Dermatology, Endocrinology +11

Improvement of psoriasis during glucagon-like peptide-1 analogue therapy in type 2 diabetes is associated with decreasing dermal γδ T-cell number: a prospective case-series study

Martin Buysschaert, Marie Baeck, Vanessa Preumont et al. · British Journal of Dermatology · 2014 · 99 citations

Medicine, Dermatology, Immunology +17